A New Light at the End of the Idiopathic Hypersomnia Tunnel

A New Light at the End of the Idiopathic Hypersomnia Tunnel

By: Sam Kashani, MD, FAASM In August 2021, Jazz Pharmaceuticals announced the US FDA approval of Xywav for the treatment of idiopathic hypersomnia in adults. Xywav, an oral solution consisting primarily of oxybate (GHB), already has approval for the treatment of...
Circadian Issues in the Sleep Doctor’s Office

Circadian Issues in the Sleep Doctor’s Office

By: Andrew Binder, MD, FAASM, FCCP I love being a sleep doctor. I often introduce myself as a “recovering pulmonary and critical care doctor.”  One of the reasons I love being a sleep doctor is that I think it is one of the few things, in my advanced age, at which I...